NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









China Life Capital

China Life Capital

Overview

China Life Capital is the professional alternative investment platform for its parent, the state-owned China Life Insurance (Group) Company. It primarily engages in private equity, real estate, and infrastructure investments.

Year Founded

2007

Portfolio Companies

3

Investments

China Life Capital investments
CompanyDateStageLead
Tripo AIJun 2026Series A+ / A++Co-investor
Cascade Pharmaceuticals, Inc.Feb 2026VC RoundCo-investor
Cascade Pharmaceuticals, Inc.Feb 2026Series CCo-investor
Vastai TechnologiesDec 2021Series B-

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing
Year Founded2007

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.